​
​

Cidara Therapeutics (CDTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Cidara Therapeutics Revenue Highlights

Latest Revenue (Y)

$63.91M

0

Cidara Therapeutics Revenue by Period

Cidara Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$63.91M-0.60%
2022-12-31$64.29M29.69%
2021-12-31$49.57M310.81%
2020-12-31$12.07M-42.30%
2019-12-31$20.91M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Cidara Therapeutics generated $63.91M in revenue during NA 2023, up -0.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Cidara Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30--100.00%
2024-06-30$302.00K-96.43%
2024-03-31$8.46M-51.87%
2023-12-31$17.58M38.25%
2023-09-30$12.72M67.03%
2023-06-30$7.61M-70.70%
2023-03-31$25.99M154.33%
2022-12-31$10.22M-74.92%
2022-09-30$40.74M555.47%
2022-06-30$6.22M-12.56%
2022-03-31$7.11M-1.61%
2021-12-31$7.22M2.11%
2021-09-30$7.08M-78.47%
2021-06-30$32.86M1264.74%
2021-03-31$2.41M-35.43%
2020-12-31$3.73M54.35%
2020-09-30$2.42M-28.77%
2020-06-30$3.39M34.07%
2020-03-31$2.53M39.39%
2019-12-31$1.81M-90.50%
2019-09-30$19.10M100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31--

Cidara Therapeutics generated - in revenue during Q3 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Cidara Therapeutics Revenue Breakdown

Cidara Therapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 23Jun 21Mar 21
Collaboration Revenue$7.61M$32.86M$2.41M

Cidara Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Collaboration Revenue (100.00%).

Cidara Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$33.43M
CDTXCidara Therapeutics$63.91M-
CLSDClearside Biomedical$8.23M$1.04M
GLYCGlycoMimetics--
CFRXContraFect--

CDTX Revenue FAQ

What is Cidara Therapeutics’s yearly revenue?

Cidara Therapeutics's yearly revenue for 2023 was $63.9M, representing a decrease of -0.60% compared to 2022. The company's yearly revenue for 2022 was $64.29M, representing an increase of 29.69% compared to 2021. CDTX's yearly revenue for 2021 was $49.57M, representing an increase of 310.81% compared to 2020.

What is Cidara Therapeutics’s quarterly revenue?

Cidara Therapeutics's quarterly revenue for Q3 2024 was $0, a -100.00% decrease from the previous quarter (Q2 2024), and a -100.00% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $302K, a -96.43% decrease from the previous quarter (Q1 2024), and a -96.03% decrease year-over-year (Q2 2023). CDTX's quarterly revenue for Q1 2024 was $8.46M, a -51.87% decrease from the previous quarter (Q4 2023), and a -67.44% decrease year-over-year (Q1 2023).

What is Cidara Therapeutics’s revenue growth rate?

Cidara Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 28.91%, and for the last 5 years (2019-2023) was 205.55%.